ABBOTT LABORATORIES;ABBVIE BAHAMAS LIMITED;ABBVIE IRELAND UNLIMITED COMPANY
发明人:
申请号:
IL22661913
公开号:
IL226619A
申请日:
2013.05.28
申请国别(地区):
IL
年份:
2016
代理人:
摘要:
Compounds of Formula (I) (I) inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).